外体非编码RNAs:对治疗潜力和骨愈合机制的新兴见解
Huixin Shi1, Yang Yang2, Hao Xing1
1Department of Plastic Surgery, The First Hospital of China Medical University, Shenyang, China.
Journal of tissue engineering
|October 7, 2024
概括
外基因组携带非编码RNA (ncRNA),通过影响细胞通信,是骨愈合的关键. 本综述探讨了它们的机制,修改的外体细胞战略和骨再生中的临床潜力.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 外体是纳米尺寸的囊泡,通过生物活性载荷,特别是非编码RNA (ncRNAs) 中介细胞间通信.
- 外体内的ncRNAs在调节骨愈合必不可少的途径方面发挥着至关重要的作用.
- 了解外体生物发生,分泌和载荷对于治疗应用至关重要.
研究的目的:
- 审查外体衍生的ncRNAs在骨愈合中的作用.
- 阐明外生体促进骨再生的分子机制.
- 讨论外体细胞修饰策略和骨科的临床应用.
主要方法:
- 文献综述侧重于外体生物发生,ncRNA功能和骨愈合机制.
- 对骨再生的外体细胞修饰策略的分析.
- 目前临床试验和基于外体细胞的治疗方法的挑战的总结.
主要成果:
- 外体细胞调节巨细胞的两极化,血管化,骨质生成和骨质细胞生成,这对骨修复至关重要.
- 修改后的外体提供了增强骨再生的有希望的策略.
- 临床试验显示出潜力,但对广泛的外体细胞治疗仍然存在挑战.
结论:
- 外体和它们的ncRNA载荷代表着加速骨愈合的重要治疗途径.
- 对外体的战略性修改可以优化它们的再生能力.
- 需要进一步的研究和临床验证,以克服基于外体的骨科疗法的挑战.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K


